Evidence map›Paper›PMID 35217596›Full record

ArticleTobacco control2023

Nicotine pouch product awareness, interest and ever use among US adults who smoke, 2021.

Mary Hrywna, Nishi J Gonsalves, Cristine D Delnevo, Olivia A Wackowski

Open access · greenAbstract read
In one paragraph

Article in Tobacco control, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 3 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 3 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Evaluating the Role of Nicotine Stereoisomer on Nicotine Pouch Abuse Liability: A Randomized Crossover Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Review
  11. The Promotion of Oral Nicotine Pouches for Non-Smoking Cessation Purposes on TikTok.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026
    Article
  12. Effects of Sweeteners and Cinnamon Flavor on Oral Nicotine Choice Behaviors.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026
    Article
  13. Use of Images to Assess Awareness and Use of Emerging Nicotine Pouch Products.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026
    Article
  14. Article
  15. Article
  16. Nicotine pouches: A wolf in sheep's clothing.Tobacco prevention & cessation · 2026
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Mary HrywnaRutgers Center for Tobacco Studies, Rutgers Biomedical and Health Sciences, New Brunswick, New Jersey, USA mary.hrywna@rutgers.edu.ORCID 0000-0002-0717-9598
Nishi J GonsalvesRutgers Center for Tobacco Studies, Rutgers Biomedical and Health Sciences, New Brunswick, New Jersey, USA.ORCID 0000-0001-5998-4903
Cristine D DelnevoRutgers Center for Tobacco Studies, Rutgers Biomedical and Health Sciences, New Brunswick, New Jersey, USA.ORCID 0000-0001-9597-4307
Olivia A WackowskiRutgers Center for Tobacco Studies, Rutgers Biomedical and Health Sciences, New Brunswick, New Jersey, USA.ORCID 0000-0001-9159-5473
Rutgers, The State University of New Jersey · US

Funding

Tobacco Industry Marketing CoreU54CA229973 · NCI · UNIVERSITY OF PENNSYLVANIA · PI CAPPELLA, JOSEPH NICHOLAS · 2018 to 2022
$18.8M
Perceptions and Impact of Modified Risk Tobacco Product Communication MessagesR37CA222002 · NCI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI WACKOWSKI, OLIVIA · 2018 to 2023
$2.1M
NCI NIH HHS R37 CA222002NCI NIH HHS U54 CA229973
6 · The paper itself

Abstract

backgroundTobacco-free nicotine pouches are one of the fastest growing tobacco product categories in the US market. However, data on awareness, appeal or ever use of these products in the USA are limited.

methodsWe surveyed a population-based sample of US adults who smoked (n=1018) between January and February 2021 about awareness, ever use of or interest in nicotine pouches. Multivariable logistic regression models explored the relationship between nicotine pouch variables and demographic and tobacco use characteristics.

resultsIn early 2021, 29.2% of adults who smoked had ever seen or heard of nicotine pouches, 5.6% had ever tried pouches and 16.8% reported interest in using pouches in the next 6 months. Adults who smoked aged 18-44 years and those who had ever used smokeless tobacco (SLT) were more likely to be aware of nicotine pouches. Interest in using nicotine pouches was more prevalent among adult smokers who planned to quit within 6 months, attempted to quit before using counselling or another tobacco product and had ever used pouches. Among adults who smoked, those with more education had lower odds of ever using nicotine pouches while those who had attempted to quit before using traditional methods or ever used SLT had higher odds of ever use.

conclusionLevels of awareness, appeal and trial of nicotine pouches among US adults who smoke were modest, with variation by age, education, quit plans and quit attempt methods. Continued surveillance is warranted, including among naïve users and users of other tobacco and nicotine products.

Indexed as

Electronic Nicotine Delivery SystemsSmoking CessationTobacco ProductsTobacco, SmokelessAdultHumansNicotineSmokingNicotineharm reductionnicotinenon-cigarette tobacco productssurveillance and monitoring

Identifiers

PMID35217596
PMCPMC9402802
OpenAlexW4214576345

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.